• By Deepti Babu, MS, CGC
  • Posted April 14, 2017

Ambry Genetics and Leading Academic Researchers Collaborate to Improve Knowledge of Genetic Risk Factors for Breast Cancer

New clinical evidence collected from >65,000 women with breast cancer demonstrates 83% of positive test results are found in genes that impact clinical management Multi-gene germline genetic testing allows for efficient analysis, maximizing risk assessment while minimizing the time needed for results. This has been particularly effective …


  • By Jackie Connor
  • Posted December 14, 2016

Dr. Fergus Couch Talks with Ambry about Recent Study Findings

At Ambry we had the exciting opportunity to talk with Dr. Fergus Couch, Mayo Clinic Researcher, about his involvement with our Mayo Clinic research collaboration.  “Breast cancer risks associated with mutations in cancer predisposition genes identified by clinical genetic testing of 60,000 breast cancer patients,” which was the largest hereditary …


  • By Jackie Connor
  • Posted November 16, 2016

Quality Genetic Testing and Why it Matters on Lifetime's 'Access Health' Television

Genetic testing has become an impactful method for clinicians to help their patients confirm their chances of inheriting a genetic disease. Testing quality is an imperative element in determining a patient’s next steps and whether their family members should also be tested.  On November 16th, Ambry CEO Aaron Elliott, PhD and Robina Smith, …